T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZLTQ
1351
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $8.21M | ﹤0.01% |
540,188
-25,005
| -4% | -$427K |
|
|
SGY
1352
DELISTED
Stone Energy
SGY
| $8.15M | ﹤0.01% |
3,067
+2,811
| +1,098% | +$7.09M |
|
|
ARC
1353
DELISTED
ARC Document Solutions, Inc.
ARC
| $8.15M | ﹤0.01% |
1,390,910
-3,290
| -0.2% | -$20.8K |
|
|
ADVS
1354
DELISTED
Advent Software Inc
ADVS
| $8.1M | ﹤0.01% |
248,600
+33,200
| +15% | +$983K |
|
1355
Itaú Unibanco
ITUB
$80B
| $7.95M | ﹤0.01% |
1,378,212
-142,909
| -9% | -$842K |
|
|
INFI
1356
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $7.93M | ﹤0.01% |
622,520
+6,300
| +1% | +$65.6K |
|
|
TSS
1357
DELISTED
Total System Services, Inc.
TSS
| $7.88M | ﹤0.01% |
250,978
-4,200
| -2% | -$129K |
|
1358
Oil States International
OIS
$543M
| $7.88M | ﹤0.01% |
122,930
-82,748
| -40% | -$4.87M |
|
1359
LKQ Corp
LKQ
$6.42B
| $7.88M | ﹤0.01% |
295,167
-38,809
| -12% | -$1.07M |
|
1360
Allegion
ALLE
$14.1B
| $7.86M | ﹤0.01% |
138,584
-324,870
| -70% | -$17.1M |
|
|
TYPE
1361
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $7.85M | ﹤0.01% |
278,520
+22,800
| +9% | +$619K |
|
|
GTLS
1362
DELISTED
Chart Industries
GTLS
| $7.83M | ﹤0.01% |
94,700
+6,200
| +7% | +$470K |
|
1363
Revvity
RVTY
$13.1B
| $7.83M | ﹤0.01% |
167,109
-2,100
| -1% | -$94.3K |
|
|
PAY
1364
DELISTED
Verifone Systems Inc
PAY
| $7.72M | ﹤0.01% |
209,947
+24,532
| +13% | +$836K |
|
|
NWY
1365
DELISTED
New York & Co Inc
NWY
| $7.66M | ﹤0.01% |
2,076,021
+95,861
| +5% | +$399K |
|
1366
Harmonic Inc
HLIT
$1.51B
| $7.65M | ﹤0.01% |
1,025,123
+8,100
| +0.8% | +$58.3K |
|
|
ASNA
1367
DELISTED
Ascena Retail Group, Inc.
ASNA
| $7.63M | ﹤0.01% |
22,322
-2,515
| -10% | -$860K |
|
|
PBCT
1368
DELISTED
People's United Financial Inc
PBCT
| $7.58M | ﹤0.01% |
499,627
| – | – |
|
1369
Assurant
AIZ
$13.9B
| $7.53M | ﹤0.01% |
114,860
-6,000
| -5% | -$401K |
|
|
ARAV
1370
DELISTED
Aravive, Inc. Common Stock
ARAV
| $7.5M | ﹤0.01% |
+44,583
| New | +$7.69M |
|
|
AFSI
1371
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $7.49M | ﹤0.01% |
358,186
+14,000
| +4% | +$287K |
|
|
KW
1372
DELISTED
Kennedy-Wilson Holdings
KW
| $7.48M | ﹤0.01% |
278,843
+54,900
| +25% | +$1.31M |
|
1373
Leggett & Platt
LEG
$1.33B
| $7.35M | ﹤0.01% |
214,336
+2,000
| +0.9% | +$66.6K |
|
1374
Accuray
ARAY
$33.1M
| $7.33M | ﹤0.01% |
832,720
+396,080
| +91% | +$3.43M |
|
1375
Ryder
R
$10.2B
| $7.32M | ﹤0.01% |
83,075
+800
| +1% | +$67K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.